Provention Bio Inc (PRVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PRVB | NTLA | JANX | ||
| Company | Provention Bio Inc | Intellia Thera CS | Janux Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.99 | 25.07 | 46.36 | ||
| High | 25.00 | 25.25 | 47.36 | ||
| Low | 24.98 | 22.64 | 43.89 | ||
| Last | 24.98 | 22.72 | 47.26 | ||
| Change | +0.75 | -2.12 | +1.89 | ||
| % Change | +3.10% | -8.53% | +4.17% | ||
| Volume | 9,124,100 | 2,021,200 | 578,400 | ||
| 20-Day Average Volume | 2,505,925 | 1,359,960 | 854,520 | ||
| Previous Close | 24.23 | 24.84 | 45.37 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.34 | 24.52 | 51.84 | ||
| 20-Day Raw Stochastic | 98.15% | 24.19% | 19.91% | ||
| 20-Day Relative Strength | 79.66% | 41.95% | 50.30% | ||
| Weighted Alpha | +19.60 | -49.34 | -32.83 | ||
| Today's Opinion | 100% Buy | 80% Sell | 72% Buy | ||
| Previous Opinion | 88% Buy | 56% Sell | 56% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.21% since 04/19/23 | -12.24% since 05/20/24 | -1.52% since 05/20/24 | ||
| Low | 24.20 on 04/25/23 | 22.64 on 05/28/24 | 42.70 on 05/24/24 | ||
| High | 25.00 on 04/26/23 | 26.46 on 05/22/24 | 48.44 on 05/21/24 | ||
| 1-Month | |||||
| %Chg | +4.56% since 03/24/23 | +9.44% since 04/26/24 | -0.27% since 04/26/24 | ||
| Low | 23.82 on 03/27/23 | 21.06 on 04/29/24 | 42.70 on 05/24/24 | ||
| High | 25.00 on 04/26/23 | 27.17 on 05/15/24 | 65.60 on 05/03/24 | ||
| 3-Month | |||||
| %Chg | +186.80% since 01/26/23 | -30.73% since 02/28/24 | +1.43% since 02/28/24 | ||
| Low | 6.59 on 03/10/23 | 19.37 on 04/26/24 | 34.63 on 04/05/24 | ||
| High | 25.00 on 04/26/23 | 34.87 on 02/29/24 | 65.60 on 05/03/24 | ||
| 6-Month | |||||
| %Chg | +279.64% since 10/26/22 | -26.11% since 11/28/23 | +375.45% since 11/28/23 | ||
| Low | 6.38 on 10/28/22 | 19.37 on 04/26/24 | 7.79 on 02/05/24 | ||
| High | 25.00 on 04/26/23 | 34.87 on 02/29/24 | 65.60 on 05/03/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,367,629 | 2,396,439 | 2,352,480 | ||
| Shares Outstanding, K | 94,781 | 96,475 | 51,851 | ||
| Annual Sales | 12,900,000 | 36,280,000 | 8,080,000 | ||
| Annual Net Income | -113,570,000 | -481,190,000 | -58,290,000 | ||
| Last Quarter Sales | 10,810,000 | 28,940,000 | 1,250,000 | ||
| Last Quarter Net Income | -33,280,000 | -107,440,000 | -14,760,000 | ||
| 60-Month Beta | 2.47 | 1.85 | 3.87 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.38 on 03/29/23 | -1.06 on 05/09/24 | -0.30 on 05/07/24 | ||
| Latest Earnings Date | 05/04/23 | 05/09/24 | 05/14/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||